These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8143848

  • 1. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis.
    Swain JA, Darley-Usmar V, Gutteridge JM.
    FEBS Lett; 1994 Mar 28; 342(1):49-52. PubMed ID: 8143848
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities.
    Gutteridge JM.
    Chem Biol Interact; 1985 Dec 17; 56(1):113-20. PubMed ID: 3000633
    [Abstract] [Full Text] [Related]

  • 3. Plasma ascorbate levels and inhibition of the antioxidant activity of caeruloplasmin.
    Gutteridge JM.
    Clin Sci (Lond); 1991 Sep 17; 81(3):413-7. PubMed ID: 1717196
    [Abstract] [Full Text] [Related]

  • 4. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material.
    Swain J, Gutteridge JM.
    FEBS Lett; 1995 Jul 24; 368(3):513-5. PubMed ID: 7635210
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Caeruloplasmin: a plasma protein, enzyme, and antioxidant.
    Gutteridge JM.
    Ann Clin Biochem; 1978 Nov 24; 15(6):293-6. PubMed ID: 736489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper.
    Gutteridge JM, Winyard PG, Blake DR, Lunec J, Brailsford S, Halliwell B.
    Biochem J; 1985 Sep 01; 230(2):517-23. PubMed ID: 4052055
    [Abstract] [Full Text] [Related]

  • 9. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF, Ahmed HA, Seymour CA.
    Biochem J; 1996 May 01; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [Abstract] [Full Text] [Related]

  • 10. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A, Yacoubian C, Beetham R, Catchpole A, Bullock D.
    Ann Clin Biochem; 2017 Nov 01; 54(6):649-654. PubMed ID: 27742851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Does caeruloplasmin dismute superoxide? No.
    Bannister JV, Bannister WH, Hill HA, Mahood JF, Willson RL, Wolfenden BS.
    FEBS Lett; 1980 Aug 25; 118(1):127-9. PubMed ID: 6250904
    [No Abstract] [Full Text] [Related]

  • 13. An automated method for the kinetic measurement of ferroxidase activity.
    Winkles J, Jones AF, Winyard P, Blake DR, Lunec J.
    Ann Clin Biochem; 1988 May 25; 25 ( Pt 3)():250-4. PubMed ID: 3400981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hormonally produced changes in caeruloplasmin synthesis and secretion in primary cultured rat hepatocytes. Relationship to hepatic copper metabolism.
    Weiner AL, Cousins RJ.
    Biochem J; 1983 May 15; 212(2):297-304. PubMed ID: 6882374
    [Abstract] [Full Text] [Related]

  • 16. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
    Wolf TL, Kotun J, Meador-Woodruff JH.
    Schizophr Res; 2006 Sep 15; 86(1-3):167-71. PubMed ID: 16842975
    [Abstract] [Full Text] [Related]

  • 17. A New Kinetic, Automated Assay to Determine the Ferroxidase Activity of Ceruloplasmin.
    Neselioglu S, Ergin M, Erel O.
    Anal Sci; 2017 Sep 15; 33(12):1339-1344. PubMed ID: 29225221
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation.
    Gutteridge JM.
    FEBS Lett; 1983 Jun 27; 157(1):37-40. PubMed ID: 6862018
    [Abstract] [Full Text] [Related]

  • 20. Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patients.
    Blake DR, Blann A, Bacon PA, Farr M, Gutteridge JM, Halliwell B.
    Clin Sci (Lond); 1983 May 27; 64(5):551-3. PubMed ID: 6403279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.